| UniProt ID | CQ080_HUMAN | |
|---|---|---|
| UniProt AC | Q9BSJ5 | |
| Protein Name | Uncharacterized protein C17orf80 | |
| Gene Name | C17orf80 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 609 | |
| Subcellular Localization |
Membrane Single-pass membrane protein . |
|
| Protein Description | ||
| Protein Sequence | MSDNPPRMEVCPYCKKPFKRLKSHLPYCKMIGPTIPTDQKVYQSKPATLPRAKKMKGPIKDLIKAKGKELETENEERNSKLVVDKPEQTVKTFPLPAVGLERAATTKADKDIKNPIQPSFKMLKNTKPMTTFQEETKAQFYASEKTSPKRELAKDLPKSGESRCNPSEAGASLLVGSIEPSLSNQDRKYSSTLPNDVQTTSGDLKLDKIDPQRQELLVKLLDVPTGDCHISPKNVSDGVKRVRTLLSNERDSKGRDHLSGVPTDVTVTETPEKNTESLILSLKMSSLGKIQVMEKQEKGLTLGVETCGSKGNAEKSMSATEKQERTVMSHGCENFNTRDSVTGKESQGERPHLSLFIPRETTYQFHSVSQSSSQSLASLATTFLQEKKAEAQNHHCVPDVKALMESPEGQLSLEPKSDSQFQASHTGCQSPLCSAQRHTPQSPFTNHAAAAGRKTLRSCMGLEWFPELYPGYLGLGVLPGKPQCWNAMTQKPQLISPQGERLSQVSLLERSSTHIRSLEPPAGLTTSNFSLMRLLGAVQKGWIRCNTTIRKSGFGGITMLFTGYFVLCCSWSFRRLKKLCRPLPWKSTVPPCIGVAKTTGDCRSKTCLD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 45 | Malonylation | DQKVYQSKPATLPRA CCCHHCCCCCCCCCH | 24.13 | 32601280 | |
| 48 | Phosphorylation | VYQSKPATLPRAKKM HHCCCCCCCCCHHHC | 45.91 | 24719451 | |
| 56 | Acetylation | LPRAKKMKGPIKDLI CCCHHHCCCCHHHHH | 71.11 | 7851337 | |
| 64 | Acetylation | GPIKDLIKAKGKELE CCHHHHHHHHCCCCC | 51.87 | 7851347 | |
| 85 | Malonylation | NSKLVVDKPEQTVKT CCCEEECCHHHEEEE | 38.55 | 32601280 | |
| 92 | Phosphorylation | KPEQTVKTFPLPAVG CHHHEEEEECCCCCC | 26.58 | - | |
| 105 | Phosphorylation | VGLERAATTKADKDI CCCHHHHCCCCCHHC | 28.04 | - | |
| 110 | Acetylation | AATTKADKDIKNPIQ HHCCCCCHHCCCCCC | 67.23 | 26051181 | |
| 126 | Phosphorylation | SFKMLKNTKPMTTFQ HHHHHCCCCCCCCCC | 34.63 | 17192257 | |
| 127 | Acetylation | FKMLKNTKPMTTFQE HHHHCCCCCCCCCCH | 42.03 | 26051181 | |
| 130 | Phosphorylation | LKNTKPMTTFQEETK HCCCCCCCCCCHHHH | 32.74 | 29978859 | |
| 131 | Phosphorylation | KNTKPMTTFQEETKA CCCCCCCCCCHHHHH | 19.64 | 29978859 | |
| 136 | Phosphorylation | MTTFQEETKAQFYAS CCCCCHHHHHHHHHC | 30.81 | 29978859 | |
| 141 | Phosphorylation | EETKAQFYASEKTSP HHHHHHHHHCCCCCC | 9.35 | 29978859 | |
| 143 | Phosphorylation | TKAQFYASEKTSPKR HHHHHHHCCCCCCHH | 28.39 | 29978859 | |
| 146 | Phosphorylation | QFYASEKTSPKRELA HHHHCCCCCCHHHHH | 46.33 | 29978859 | |
| 147 | Phosphorylation | FYASEKTSPKRELAK HHHCCCCCCHHHHHH | 39.22 | 29978859 | |
| 172 | Phosphorylation | NPSEAGASLLVGSIE CHHHHCHHEEEEECC | 22.71 | 23532336 | |
| 177 | Phosphorylation | GASLLVGSIEPSLSN CHHEEEEECCCCCCC | 19.12 | 23532336 | |
| 190 | Phosphorylation | SNQDRKYSSTLPNDV CCCCCCCCCCCCCCC | 21.63 | 28555341 | |
| 225 | Phosphorylation | VKLLDVPTGDCHISP HHHHCCCCCCCCCCC | 45.56 | 29978859 | |
| 231 | Phosphorylation | PTGDCHISPKNVSDG CCCCCCCCCCCHHHH | 13.22 | 27050516 | |
| 268 | Phosphorylation | VPTDVTVTETPEKNT CCCCCEEEECCCCCC | 25.44 | 28555341 | |
| 270 | Phosphorylation | TDVTVTETPEKNTES CCCEEEECCCCCCHH | 27.64 | 25627689 | |
| 281 | Phosphorylation | NTESLILSLKMSSLG CCHHHHHHHHHHHCC | 20.96 | 24719451 | |
| 301 | Phosphorylation | EKQEKGLTLGVETCG EHHHCCCEEEEEECC | 30.09 | - | |
| 306 | Phosphorylation | GLTLGVETCGSKGNA CCEEEEEECCCCCCH | 21.54 | - | |
| 340 | Phosphorylation | ENFNTRDSVTGKESQ CCCCCCCCCCCCCCC | 20.49 | 28555341 | |
| 342 | Phosphorylation | FNTRDSVTGKESQGE CCCCCCCCCCCCCCC | 46.63 | 29214152 | |
| 346 | Phosphorylation | DSVTGKESQGERPHL CCCCCCCCCCCCCEE | 47.15 | 29214152 | |
| 404 | Sulfoxidation | VPDVKALMESPEGQL CCCHHHHHCCCCCCC | 5.99 | 21406390 | |
| 406 | Phosphorylation | DVKALMESPEGQLSL CHHHHHCCCCCCCCC | 17.81 | 29523821 | |
| 417 | Phosphorylation | QLSLEPKSDSQFQAS CCCCCCCCCCCCHHH | 53.89 | 22210691 | |
| 419 | Phosphorylation | SLEPKSDSQFQASHT CCCCCCCCCCHHHCC | 39.73 | 22210691 | |
| 424 | Phosphorylation | SDSQFQASHTGCQSP CCCCCHHHCCCCCCC | 15.70 | 22210691 | |
| 439 | Phosphorylation | LCSAQRHTPQSPFTN CCCCCCCCCCCCCCC | 25.80 | - | |
| 442 | Phosphorylation | AQRHTPQSPFTNHAA CCCCCCCCCCCCHHH | 24.16 | 25159151 | |
| 552 | Phosphorylation | CNTTIRKSGFGGITM CCCCHHHCCCCCEEE | 29.52 | 22210691 | |
| 558 | Phosphorylation | KSGFGGITMLFTGYF HCCCCCEEEEEEEEH | 15.88 | 22210691 | |
| 562 | Phosphorylation | GGITMLFTGYFVLCC CCEEEEEEEEHHHHH | 27.32 | 22210691 | |
| 605 | Acetylation | TTGDCRSKTCLD--- CCCCCCCCCCCC--- | 24.73 | 7960577 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CQ080_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CQ080_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CQ080_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| KCNA5_HUMAN | KCNA5 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-126, AND MASSSPECTROMETRY. | |